J.B. Chemicals & Pharmaceuticals (BOM:506943) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506943 J.B. Chemicals & Pharmaceuticals Ltd BOM:506943
85 GF Score
Price ₹2,412.25
GF Value ₹1,950.89
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is J.B. Chemicals & Pharmaceuticals Cash Flow for Dividends?

J.B. Chemicals & Pharmaceuticals BOM:506943 85 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:506943 with a GF Score™ of 85/100 and a GF Value™ of ₹1,950.89 (Modestly Overvalued). The stock has 6 warning signs investors should review.

J.B. Chemicals & Pharmaceuticals's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

J.B. Chemicals & Pharmaceuticals's annual payment of dividends increased from Mar. 2024 (₹-1,570 Mil) to Mar. 2025 (₹-2,370 Mil) and increased from Mar. 2025 (₹-2,370 Mil) to Mar. 2026 (₹-3,133 Mil).

J.B. Chemicals & Pharmaceuticals Cash Flow for Dividends Related Terms

J.B. Chemicals & Pharmaceuticals Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for J.B. Chemicals & Pharmaceuticals's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J.B. Chemicals & Pharmaceuticals Cash Flow for Dividends Chart

J.B. Chemicals & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,275.60 -1,275.93 -1,569.88 -2,370.42 -3,132.93

J.B. Chemicals & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:506943
85GF Score
J.B. Chemicals & Pharmaceuticals Ltd BOM:506943
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J.B. Chemicals & Pharmaceuticals Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
J.B. Chemicals & Pharmaceuticals (BOM:506943) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for J.B. Chemicals & Pharmaceuticals and its competitors.
Is J.B. Chemicals & Pharmaceuticals' Cash Flow for Dividends too high?
J.B. Chemicals & Pharmaceuticals' current Cash Flow for Dividends is ₹0 Mil. Overall, J.B. Chemicals & Pharmaceuticals has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does J.B. Chemicals & Pharmaceuticals' Cash Flow for Dividends compare to ZTS?
J.B. Chemicals & Pharmaceuticals' Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for J.B. Chemicals & Pharmaceuticals and its competitors. J.B. Chemicals & Pharmaceuticals's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J.B. Chemicals & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, J.B. Chemicals & Pharmaceuticals (BOM:506943) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,950.89, compared to a current price of ₹2,412.25 — trading 23.6% above its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. J.B. Chemicals & Pharmaceuticals' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For J.B. Chemicals & Pharmaceuticals (BOM:506943), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is J.B. Chemicals & Pharmaceuticals (BOM:506943) Overvalued in 2026?

Based on GuruFocus' analysis, J.B. Chemicals & Pharmaceuticals stock appears to be overvalued. The current stock price of ₹2,412.25 is trading 23.6% above its estimated GF Value™ of ₹1,950.89. GuruFocus considers J.B. Chemicals & Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:506943:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹1,950.89 vs. price of ₹2,412.25 (23.6% above fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the BOM:506943 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

J.B. Chemicals & Pharmaceuticals Business Description

Other Exchanges JBCHEPHARM:India
Address Appa Saheb Marathe Marg, Cnergy IT Park, Unit A2, 3rd floor and Unit A, 8th floor, Prabhadevi, Mumbai, MH, IND, 400 025
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, capsules, lozenges, syrups and injectables. It has only one reportable business segment, i.e., Pharmaceuticals. The Company derives revenue from the manufacturing and marketing of pharmaceutical products. The company sells its products in India and also exports them to other international countries. The maximum revenue is generated from India.
85GF Score

Get the complete analysis for BOM:506943

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,412.25
Price
₹1,950.89
GF Value